View Page As PDF
Share Button
Tweet Button
Federal regulators have barred Elizabeth Holmes, chief executive of Theranos, from owning or operating a medical laboratory for at least two years, raising new questions about the future of the embattled blood-testing start-up and its founder, once a Silicon Valley phenomenon.

In a letter sent to Theranos that was made public on Friday, regulators said they were revoking the certification of its flagship laboratory in Newark, Calif., effective Sept. 5. They also said the laboratory would be prohibited from taking Medicare and Medicaid payments.

The government scrutiny stemmed from questions about the effectiveness of Theranos’s technology and the way the company operated its labs.

Click here to see Jane Pine Wood's quote in the full article from The New York Times.
COMMENT
+